Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) price on Thursday, April 18, fall -0.58% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $13.10.
A look at the stock’s price movement, the level at last check in today’s session was $13.18. Turning to its 52-week performance, $14.47 and $7.09 were the 52-week high and 52-week low respectively. Overall, TEVA moved -1.85% over the past month.
Teva- Pharmaceutical Industries Ltd. ADR’s market cap currently stands at around $14.69 billion. Analysts project the company’s earnings per share (EPS) to be $0.52, which has seen fiscal year 2024 EPS growth forecast to increase to $2.41 and about $2.64 for fiscal year 2025. Per the data, EPS growth is expected to be -5.90% for 2024 and 9.50% for the next financial year.
Analysts have a consensus estimate of $3.73 billion for the company’s revenue for the quarter, with a low and high estimate of $3.63 billion and $3.82 billion respectively. The average forecast suggests up to a 2.80% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue for 2024 to grow to $15.87 billion, representing a 0.10% jump on that reported in the last financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that TEVA is a 50% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
TEVA’s current price about -5.26% and -2.30% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 39.37, while 7-day volatility ratio is 2.90% and 2.41% in the 30-day chart. Further, Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has a beta value of 1.07, and an average true range (ATR) of 0.34.
If we refocus on Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA), historical trading data shows that trading volumes averaged 10.43 million over the past 3 months. The company’s latest data on shares outstanding shows there are 1.12 billion shares.
The 0.01% of Teva- Pharmaceutical Industries Ltd. ADR’s shares are in the hands of company insiders while institutional holders own 52.44% of the company’s shares. Current price change has pushed the stock 25.51% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TEVA stock continues to rise going into the next quarter.
